Scott IA, Hilmer SN, Reeve E, Potter K, Couteur DL et al (2015) Reducing inappropriate

polypharmacy: the process of deprescribing. JAMA Intern Med 175(5):827–834. https://doi.

org/10.1001/jamainternmed.2015.0324

Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of

bacterial to host cells in humans. Cell 164(3):337–340

Serra-Prat M, Mans E, Palomera E, Clave P (2013) Gastrointestinal peptides, gastrointestinal

motility, and anorexia of aging in frail elderly persons. Neurogastroenterol Motil 25(4):291–

e245

Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM (2016) Polypharmacy and potentially

inappropriate medication use in geriatric oncology. J Geriatr Oncol 7(5):346–353. https://doi.

org/10.1016/j.jgo.2016.07.010

Shehab-Eldin W, Shaaban M, Atia AS, Zewain SK (2020) The association between thyroid

function and nutritional status in patients with end-stage renal disease on hemodialysis. Alex

J Med 56(1):220–225

Skinner MH, Kuan H-Y, Skerjanec A, Seger ME, Heathman M, O’Bian L, Reddy S, Knadler MP

(2003) Effect of age on the pharmacokinetics of duloxetine in women. Br J Clin Pharmacol

57(1):54–61

Sparkman NL, Li M (2012) Drug–drug conditioning between citalopram and haloperidol or

olanzapine in a conditioned avoidance response model: implications for polypharmacy in

schizophrenia. Behav Pharmacol 23(7):658–668

Stout SM, Nielsen J, Bleske BE, Shea M, Brook R, Kerber K, Welage LS (2010) The impact of

paroxetine coadministration on stereospecific carvedilol pharmacokinetics. J Cardiovasc

Pharmacol Ther 15(4):373–379

Streeter AJ, Faria EC (2017) Analysis of the variability of the pharmacokinetics of multiple drugs in

young adult and elderly subjects and its implication for acceptable daily exposures and cleaning

validation limits. Int J Hyg Environ Health 220(4):659–672

Szalach LP, Lisowska KA, Cubala WJ (2019) The influence of antidepressants on the immune

system. Arch Immunol Ther Exp 67:143–151

Taylor WD (2015) Should antidepressant medication be used in the elderly? Expert Rev Neurother

15(9):961–963

Telessy IG, Buttar HS (2017) Obesity related alterations in pharmacokinetics and pharmacodynam-

ics of drugs: emerging clinical implications in obese patients—part II. Adipobiology 9:31–40

Tiihonen K, Ouweh AC, Rautonen N (2010) Human intestinal microbiota and healthy ageing.

Ageing Res Rev 9(2):107–116

Timmer CJ, Sitsen JM, Delbressine LP (2000) Clinical pharmacokinetics of mirtazepine. Clin

Pharmacokinet 38(6):461–474

Tjia J, Lapane K (2017) Guideline-based prescribing in frail elderly patients. JAMA Intern Med

177(2):262–263

Tolson D, Rolland Y, Andrieu S, Aquino J-P et al (2011) International Association of Gerontology

and Geriatrics: a global agenda for clinical research and quality of care in nursing homes. J Am

Med Dir Assoc 12:184–189

Trautinger F (2001) Mechanisms of photodamage of the skin and its functional consequences for

skin ageing. Clin Exp Dermatol 26(7):573–577

Turnheim K (1998) Drug dosage in the elderly. Is it rational? Drugs Aging 13(5):357–379

van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, Lammertsma

AA, van Berckel BN (2012) P-glycoprotein function at the blood-brain barrier: effects of age

and gender. Mol Imaging Biol 14(6):771–776

van der Lee MJ, Blenke AAM, Rongen GA, Verwey-van Wissen CPWGM, Koopmans PP,

Pharo C, Burger DM (2007) Interaction study of the combined use of paroxetine and

fosamprenavir-ritonavir in healthy subjects. Antimicrob Agents Chemother 51(11):4098–4104

Vemuri R, Gundamaraju R, Shastri MD, Shukla SD, Kalpurath K, Ball M, Tristram S, Shankar EM,

Ahuja K, Eri R (2018) Gut microbial hanges, interactions, and their implications on human

lifecycle: an ageing perspective. Biomed Res Int 2018:4178607. 1–13

15

The Importance of Drug Dose Adjustment in Elderly Patients with Special. . .

271